Rare diseases
Investigational molecules
Locations
Back to Italy213 clinical trials in Aviano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis
ItalyStudy on Trabectedin and Radiotherapy for Patients with Soft Tissue Sarcoma
ItalyStudy of Tremelimumab for Patients with Unresectable Malignant Mesothelioma
ItalyItalyStudy Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
ItalyStudy of Atezolizumab with Drug Combination for Patients with Unresectable Metastatic Colorectal Cancer
ItalyStudy of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes
ItalyStudy of Atezolizumab and Chemotherapy for Patients with Relapsed Small Cell Lung Cancer
ItalyStudy on Temozolomide and Irinotecan for Patients with Stage II/III Colorectal Cancer and Positive ctDNA After Chemotherapy
ItalyStudy of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer
ItalyStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
ItalyStudy on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring new treatment combinations for non-small cell lung cancer (NSCLC), including studies of novel immunotherapy approaches and targeted therapies. Research focuses on improving outcomes for patients with advanced stages of the disease.
Clinical investigations targeting hormone receptor-positive and triple-negative breast cancers, evaluating novel therapeutic combinations and treatment strategies for both early-stage and metastatic disease.
Research examining innovative approaches for metastatic colorectal cancer, including studies of targeted therapies and immunotherapy combinations. Focus on personalized treatment strategies based on molecular profiles.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
